Stephanie Rawlings-Rhea
Seattle Children's Hospital(US)Seattle Children's Hospital(US)Seattle University(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Virus-based gene therapy research, Nanowire Synthesis and Applications, Glioma Diagnosis and Treatment
Most-Cited Works
- → CD19 CAR T cell product and disease attributes predict leukemia remission durability(2019)338 cited
- → Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis(2021)297 cited
- → Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety(2022)246 cited
- → Glial injury in neurotoxicity after pediatric CD19‐directed chimeric antigen receptor T cell therapy(2019)181 cited
- → Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial(2025)103 cited
- → Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing(2024)44 cited
- → STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors(2024)33 cited
- → GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients(2022)28 cited
- → STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed/refractory solid tumors.(2022)27 cited
- → Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects(2022)26 cited